Panel Discussion: Bridging Science and Strategy: Funding the Next Wave of Dermatology Innovation
- Trends in capital allocation across indications, modalities, and stages of development in dermatology
- Key factors that shape investor and pharma conviction in early-stage assets and platforms
- How clinical trial design, endpoints, and market access considerations influence fundability
- Strategies for building successful partnerships and aligning with pharma and investor expectations